XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated and Combined Statements of Operations (Unaudited) - USD ($)
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Income Statement [Abstract]    
Net sales
Cost of goods sold
Gross profit
Operating Expenses    
Research and development 1,353,050 729,114
Selling, general and administrative 1,779,619 3,030,222
Total operating expenses 3,132,669 3,759,336
Operating loss (3,132,669) (3,759,336)
Other Income (Expense)    
Change in fair value of derivative liabilities 12,417,450 (8,182,500)
Issuance of common stock and warrants (20,590,717)
Interest income 16,271 311
Interest expense (106,422) (3,739)
Other income (expense) (1)
Total other income (expense) 12,327,299 (28,776,646)
Net income (loss) before provision for income taxes 9,194,630 (32,535,982)
Provision for income taxes
Net income (loss) $ 9,194,630 $ (32,535,982)
Weighted average number of shares of common stock outstanding, basic (in Shares) 3,001,784 1,585,049
Basic net income (loss) per share of common stock (in Dollars per share) $ 3.06 $ (20.53)
Weighted average number of shares of common stock outstanding, diluted (in Shares) 3,023,585 1,585,049
Diluted net income (loss) per share of common stock (in Dollars per share) $ 3.04 $ (20.53)